Regeneron Pharmaceuticals, Inc. (REGN)
698.25
-14.62
(-2.05%)
USD |
NASDAQ |
May 15, 16:00
698.50
+0.25
(+0.04%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Liabilities (Quarterly) : 9.445B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| AbbVie, Inc. | 143.08B |
| Biogen, Inc. | 10.83B |
| Eli Lilly & Co. | 85.38B |
| Merck & Co., Inc. | 82.75B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.87B |
| Shareholders Equity (Quarterly) | 31.42B |
| Debt to Equity Ratio | 0.0861 |
| Current Ratio | 3.565 |
| Net Debt Paydown Yield | 0.06% |